Cited by 121Maternal and fetal healthcareBlood transfusion and managementTrauma, Hemostasis, Coagulopathy, Resuscitation

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Massive blood transfusion during hospitalization for delivery in New York State, 1998-2007

Open access

Abstract

OBJECTIVE: To define the frequency, risk factors, and outcomes of massive transfusion in obstetrics. METHODS: The State Inpatient Dataset for New York (1998-2007) was used to identify all delivery hospitalizations for hospitals that reported at least one delivery-related transfusion per year. Multivariable logistic regression analysis was performed to examine the relationship between maternal age, race, and relevant clinical variables and the risk of massive blood transfusion defined as 10 or more units of blood recorded. RESULTS: Massive blood transfusion complicated 6 of every 10,000 deliveries with cases observed even in the smallest facilities. Risk factors with the strongest independent associations with massive blood transfusion included abnormal placentation (1.6/10,000 deliveries, adjusted odds ratio [OR] 18.5, 95% confidence interval [CI] 14.7-23.3), placental abruption (1.0/10,000, adjusted OR 14.6, 95% CI 11.2-19.0), severe preeclampsia (0.8/10,000, adjusted OR 10.4, 95% CI 7.7-14.2), and intrauterine fetal demise (0.7/10,000, adjusted OR 5.5, 95% CI 3.9-7.8). The most common etiologies of massive blood transfusion were abnormal placentation (26.6% of cases), uterine atony (21.2%), placental abruption (16.7%), and postpartum hemorrhage associated with coagulopathy (15.0%). A disproportionate number of women who received a massive blood transfusion experienced severe morbidity including renal failure, acute respiratory distress syndrome, sepsis, and in-hospital death. CONCLUSION: Massive blood transfusion was infrequent, regardless of facility size. In the presence of known risk for receipt of massive blood transfusion, women should be informed of this possibility, should deliver in a well-resourced facility if possible, and should receive appropriate blood product preparation and venous access in advance of delivery. LEVEL OF EVIDENCE: : II.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/aog.0000000000000021

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a large retrospective cohort study in New York (1998-2007), massive transfusion occurred in 6 per 10,000 deliveries, and abruption was a strong independent risk factor (occurring in 1 per 10,000 deliveries; adjusted OR 14.6, 95% CI 11.2-19.0).

    “In a large retrospective cohort study that included all delivery hospitalizations for hospitals that reported at least one delivery-related transfusion per year in New York (1998–2007), massive transfusion occurred in 6 per 10,000 deliveries, and abruption was a strong independent risk factor (occurring in 1 per 10,000 deliveries; adjusted OR 14.6, 95% CI 11.2–19.0) (80).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Mhyre, J. M., Shilkrut, A., Kuklina, E. V., Callaghan, W. M., Creanga, A. A., Kaminsky, S., & Bateman, B. T.
Affiliations
Brigham and Women's Hospital (US)
Venue
Obstetrics & Gynecology
Published
2013-12
Volume
122
Issue
6
Pages
1288-1294
ISSN
0029-7844 (ISSN-L)
OpenAlex
W2080957457
Cited by
121
References
23
Citations by year
2026: 1 · 2025: 6 · 2024: 6 · 2023: 13 · 2022: 11 · 2021: 14 · 2020: 10 · 2019: 14 · 2018: 8 · 2017: 14 · 2016: 7 · 2015: 11 · 2014: 6
FWCI
7.45
Type
journal article
Language
en
Open access
Locations
  • Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Touro Scholar (Touro College) (submittedVersion)
Funders
National Institutes of Health (CC999999)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and fetal healthcare
  • Health Sciences › Medicine › Hematology › Blood transfusion and management
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
Keywords
massive transfusion, obstetric hemorrhage, postpartum hemorrhage, placental abruption, abnormal placentation, severe preeclampsia, intrauterine fetal death, uterine atony, coagulopathy, risk factors, maternal morbidity, in-hospital mortality, New York State
MeSH terms
Adult, Blood Coagulation Disorders, Blood Transfusion, Cross-Sectional Studies, Female, Fetal Death, Postpartum Hemorrhage, Humans, New York, Placenta Diseases, Pre-Eclampsia, Pregnancy, Retrospective Studies, Risk Factors, Uterine Inertia, Delivery, Obstetric, Young Adult, Transfusion Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review